12/3/2021, 10:05 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Pfizer Inc

Pfizer drug likely to retain effect against Omicron - Fauci

United States National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci said on Friday that Pfizer's oral drug against COVID-19 is likely to retain its effect against the Omicron variant of the virus, backing the comments of the company's CEO Albert Bourla.

Fauci also noted that there is "no doubt" the US has a community spread of the new variant after cases of it were registered in five states, including New York.

Earlier, GlaxoSmithKline stated preclinical data showed its COVID-19 drug also "retains activity against key mutations of the Omicron variant."

Baha Breaking News (BBN) / NP